Corpus ID: 139357045

Development of validated analytical methods for selected Cardiovascular Drugs in formulations and its application in in-vitro interaction studies.

@inproceedings{Shivashankar2015DevelopmentOV,
  title={Development of validated analytical methods for selected Cardiovascular Drugs in formulations and its application in in-vitro interaction studies.},
  author={V. Shivashankar},
  year={2015}
}
A simple RP-HPLC method has been developed and validated for the estimation of Rivaroxaban in formulation. Rivaroxaban is a direct factor Xa inhibitor which is indicated for the prevention various coagulative disorders. A HIBAR5μ C18 column (250×4.6mm) was used as a stationary phase. The mobile phase consisted of potassium dihydrogen orthophosphate buffer (pH adjusted to 3.0 with orthophosphoric acid): Acetonitrile in the ratio of 60:40 % v/v and the flow rate was 1 ml/min. The detection was… Expand

Figures and Tables from this paper

References

SHOWING 1-10 OF 43 REFERENCES
...
1
2
3
4
5
...